<p>The present invention provides a pharmaceutical composition which causes skipping of the 53rd exon in the human dystrophin gene with a high efficiency. The present invention provides an oligomer which efficiently enables to cause skipping of the 53rd exon in the human dystrophin gene.</p>
申请公布号
EP2612917(A1)
申请公布日期
2013.07.10
申请号
EP20110821996
申请日期
2011.08.31
申请人
NIPPON SHINYAKU CO., LTD.;NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
